Thursday 28 March 2019 at 4:00 pm QCRI Conf. Rms. 100/01
Paul Krzyzanowski, Director, Genome Technology Translation, OICR Lars Jorgensen, Director, Genome Sequence Informatics, OICR
“Current practices in large scale cancer genomics and bioinformatics”
In our presentation we will highlight recent advances in cancer genomics and bioinformatics and illustrate how the OICR Genomics and Bioinformatics platform has helped previous projects succeed with our wide array of available services. We hope to have an interactive session and response to any questions people might have about designing genome sequencing projects and our technology platform.
The mission of the OICR Genomics & Bioinformatics team is to provide large-scale, next-generation sequencing (NGS) cancer genomics capabilities to researchers in Ontario and beyond. The OICR Genomics & Bioinformatics platform accomplishes this mission through its ability to comprehensively characterize an assortment of sample types: tumours and matched normal tissues, xenografts, cell lines derived from tumours, and circulating nucleic acids using a wide array of technologies including Illumina short read sequencing, Oxford Nanopore long read sequencing, 10X Genomics single cell solutions, along with many other supporting NGS products. Our key pillars:
Provide state-of-the-art DNA/RNA sample preparation, library construction and sequencing capabilities to support translational research.
Evaluate and adopt/adapt new technologies and methodologies for research and clinical applications.
Where no suitable technologies exist, develop and implement novel approaches and techniques
Paul & Lars are keen to meet with groups or individuals to discuss potential projects. Anyone interested in doing this should contact: Dr. David LeBrun - email@example.com; ext. 33209 Everyone is welcome!